Xencor Inc (XNCR)
18.47
+0.28
(+1.54%)
USD |
NASDAQ |
Apr 23, 12:24
Xencor Net Income (Quarterly): -19.10M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -19.10M |
| September 30, 2023 | -24.27M |
| June 30, 2023 | -21.95M |
| March 31, 2023 | -60.76M |
| December 31, 2022 | -12.04M |
| September 30, 2022 | -32.76M |
| June 30, 2022 | -33.98M |
| March 31, 2022 | 23.59M |
| December 31, 2021 | 73.06M |
| September 30, 2021 | -40.19M |
| June 30, 2021 | 52.25M |
| March 31, 2021 | -2.487M |
| December 31, 2020 | -13.69M |
| September 30, 2020 | -12.55M |
| June 30, 2020 | -35.02M |
| March 31, 2020 | -8.074M |
| December 31, 2019 | -26.91M |
| September 30, 2019 | -10.22M |
| June 30, 2019 | -16.03M |
| March 31, 2019 | 80.04M |
| December 31, 2018 | -18.20M |
| September 30, 2018 | 3.15M |
| June 30, 2018 | -25.87M |
| Date | Value |
|---|---|
| March 31, 2018 | -29.49M |
| December 31, 2017 | 7.367M |
| September 30, 2017 | -22.65M |
| June 30, 2017 | -7.725M |
| March 31, 2017 | -15.48M |
| December 31, 2016 | 12.44M |
| September 30, 2016 | -8.077M |
| June 30, 2016 | 47.16M |
| March 31, 2016 | -6.398M |
| December 31, 2015 | 7.757M |
| September 30, 2015 | -10.04M |
| June 30, 2015 | -8.868M |
| March 31, 2015 | -6.444M |
| December 31, 2014 | -1.349M |
| September 30, 2014 | -6.278M |
| June 30, 2014 | -5.044M |
| March 31, 2014 | -3.751M |
| December 31, 2013 | -3.703M |
| September 30, 2013 | -1.835M |
| June 30, 2013 | -50.11M |
| March 31, 2013 | -4.612M |
| December 31, 2012 | -3.111M |
| September 30, 2012 | -2.589M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-60.76M
Minimum
Mar 2023
73.06M
Maximum
Dec 2021
-11.64M
Average
-16.03M
Median
Jun 2019
Net Income (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | -9.263M |
| Karyopharm Therapeutics Inc | -41.84M |
| NovaBay Pharmaceuticals Inc | -4.108M |
| Palatin Technologies Inc | -7.844M |
| iBio Inc | -8.211M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 44.69M |
| Total Expenses (Quarterly) | 79.70M |
| EPS Diluted (Quarterly) | -0.31 |
| Enterprise Value | 539.36M |
| Profit Margin (Quarterly) | -42.74% |
| Earnings Yield | -11.37% |
| Normalized Earnings Yield | -11.08 |